Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients

BACKGROUND AND OBJECTIVE: As pazopanib plasma trough concentrations are correlated with treatment outcome, we explored whether single nucleotide polymorphisms in the elimination pathway of pazopanib affect systemic pazopanib concentrations. METHODS: The decreased function alleles CYP3A4 15389 C >...

Descripción completa

Detalles Bibliográficos
Autores principales: Bins, Sander, Huitema, Alwin D. R., Laven, Pim, Bouazzaoui, Samira el, Yu, Huixin, van Erp, Nielka, van Herpen, Carla, Hamberg, Paul, Gelderblom, Hans, Steeghs, Neeltje, Sleijfer, Stefan, van Schaik, Ron H. N., Mathijssen, Ron H. J., Koolen, Stijn L. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451710/
https://www.ncbi.nlm.nih.gov/pubmed/30367352
http://dx.doi.org/10.1007/s40262-018-0719-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451710/
https://www.ncbi.nlm.nih.gov/pubmed/30367352
http://dx.doi.org/10.1007/s40262-018-0719-5

Ejemplares similares